Milan Zdravkovic
Founder en Selma Diagnostics ApS .
Perfil
Milan Zdravkovic is the founder of Selma Diagnostics ApS, which was founded in 2016.
He is currently a Director at Empros Pharma AB since 2020.
Dr. Zdravkovic has held former positions as Director at Pila Pharma AB, Vice President at Novo Nordisk Scandinavia AB from 1998 to 2007, and Chief Medical Officer and Head of Research & Development at Swedish Orphan Biovitrum AB from 2016 to 2020.
Dr. Zdravkovic has a doctorate degree from the University of Aarhus in 1996 and another doctorate degree from the same university in 2000.
He also has a graduate degree from the University of Surrey in 2007.
Cargos activos de Milan Zdravkovic
| Empresas | Cargo | Inicio |
|---|---|---|
| Selma Diagnostics ApS | Founder | 01/05/2016 |
Empros Pharma AB
 Empros Pharma AB Pharmaceuticals: MajorHealth Technology Empros Pharma AB is a pharmaceutical company based in Sweden that focuses on developing drugs to combat obesity. The CEO is Arvid Söderhäll, and the company is located in Solna, Sweden. The Swedish company has developed a weight-loss combination product containing orlistat and acarbose, which has been tested in a randomized, placebo-controlled trial. Empros Pharma's main drug, EMP16, is designed to delay food digestion and absorption processes in the small intestine using a proprietary advanced drug delivery technology. The company was founded in 2013 by senior researchers and entrepreneurs at Uppsala University, along with external investor Flerie Invest. | Director/Board Member | 01/01/2020 |
Antiguos cargos conocidos de Milan Zdravkovic.
| Empresas | Cargo | Fin |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Chief Tech/Sci/R&D Officer | 18/08/2020 |
Novo Nordisk Scandinavia AB
 Novo Nordisk Scandinavia AB Pharmaceuticals: MajorHealth Technology Novo Nordisk Scandinavia AB develops, manufactures and markets pharmaceutical products and services. Its products include medicine for diabetes, hemophilia, growth disorders, and hormone therapy. The company is headquartered in Malmö, Sweden. | Corporate Officer/Principal | 01/01/2007 |
| PILA PHARMA AB | Director/Board Member | - |
Formación de Milan Zdravkovic.
| University of Aarhus | Doctorate Degree |
| University of Surrey | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| PILA PHARMA AB | Health Technology |
| Empresas privadas | 3 |
|---|---|
Novo Nordisk Scandinavia AB
Novo Nordisk Scandinavia AB Pharmaceuticals: MajorHealth Technology Novo Nordisk Scandinavia AB develops, manufactures and markets pharmaceutical products and services. Its products include medicine for diabetes, hemophilia, growth disorders, and hormone therapy. The company is headquartered in Malmö, Sweden. | Health Technology |
Empros Pharma AB
Empros Pharma AB Pharmaceuticals: MajorHealth Technology Empros Pharma AB is a pharmaceutical company based in Sweden that focuses on developing drugs to combat obesity. The CEO is Arvid Söderhäll, and the company is located in Solna, Sweden. The Swedish company has developed a weight-loss combination product containing orlistat and acarbose, which has been tested in a randomized, placebo-controlled trial. Empros Pharma's main drug, EMP16, is designed to delay food digestion and absorption processes in the small intestine using a proprietary advanced drug delivery technology. The company was founded in 2013 by senior researchers and entrepreneurs at Uppsala University, along with external investor Flerie Invest. | Health Technology |
| Selma Diagnostics ApS |
- Bolsa de valores
- Insiders
- Milan Zdravkovic
